Maeve Waldron-Lynch

Maeve Waldron-Lynch's work experience includes various positions in the pharmaceutical and medical fields. Maeve currently works at MorphoSys as the Global Clinical Program Head for Tafasitamab since December 2022. Before that, they served as a Senior Global Program Medical Director at the same company from April 2021 to December 2022. Prior to joining MorphoSys, Maeve worked at Novartis as a Clinical Development Medical Director from March 2018 to April 2021. Maeve also held the position of Senior Clinical Director (PD Oncology) at Roche from February 2014 to February 2018. Before that, they worked at Mundipharma as the Associate Director of Medical Science, Oncology from March 2012 to January 2014 and as a Senior Oncology Research Physician from October 2011 to March 2012. Additionally, Maeve worked at the Royal College of Physicians of Ireland as a Specialist Registrar Medical Oncology from July 2007 to February 2013 and at Yale University School of Medicine as a Clinical Fellow in Medical Oncology from October 2008 to October 2011. Maeve started their career as a Lecturer in Medicine at the National University of Ireland, Galway from July 2006 to July 2008.

Maeve Waldron-Lynch pursued their education in the field of medicine. From 1990 to 1999, they attended University College Cork, focusing on medicine. Maeve then continued their education at Yale University School of Medicine from 2008 to 2011, specializing in Medical Oncology. No specific degree names were mentioned for either of their educational experiences.